Recent papers on clinical translation patients therapeutic interventions

Sorted by publication year (newest first) via OpenAlex. List regenerates every 24h.

  1. 2026
  2. Abstract SY36-02: Human cancer models: From patient-derived systems to clinical translation

    2026 · Cancer Research · Habowski, Amber N., Kouassi, Fatim, Patel, Hardik et al.

    2026
  3. Patient-Specific Disease Modeling with hiPSCs: From Mechanisms to Clinical Translation

    2026 · Zenodo (CERN European Organization for Nuclear Research) · science, regenerative medicine

    2026
  4. Automating mHealth Development: A Prompt Engineering Approach to Translate Clinical Patient Descriptions into Nursing Basic Components

    2026 · Zenodo (CERN European Organization for Nuclear Research) · Anonymous, Anonymous, Anonymous

    2026
  5. 2026
  6. An expert opinion on the management of pediatric patients with wheezing and mild asthma: translating 2025 GINA strategy report into clinical practice in Italy

    2026 · ˜The œItalian Journal of Pediatrics/Italian journal of pediatrics · Santamaria, Francesca, Baraldi, Eugenio, Cavalieri, Luca et al.

    2026
  7. Use of knowledge translation frameworks to implement diagnosis of upper quadrant lymphedema clinical practice guideline to improve patient care

    2026 · Disability and Rehabilitation · Wampler, Meredith, Campione, Elizabeth, Newell, Alaina et al.

    2026
  8. Metastatic castration-resistant prostate cancer (mCRPC) remains lethal as adaptive resistance to standard of care therapy develops, often driven by AR splice variants alongside transcriptional and translational reprogramming. To identify strategies capable of overcoming these mechanisms, we performed an unbiased high-throughput screen of 2,480 mechanistically annotated compounds across advanced prostate cancer models. Exportin-1 (XPO1)-mediated nuclear export emerged as a critical dependency, and matrix-based combination screening uncovered robust synergy between inhibitors of XPO1 and the translation initiation factor EIF4A1. Dual inhibition induced coordinated disruption of oncogenic protein networks, including AR/AR-V7 and MYC, triggering rapid apoptosis and suppressing cell-cycle and metabolic programs. These effects extended to genetically diverse patient-derived organoids and in vivo xenografts at doses well below established tolerability limits. Together, these findings reveal concurrent control of nuclear export and protein translation as a therapeutic vulnerability in mCRPC, providing a strong rationale for clinical evaluation of XPO1-EIF4A1 co-inhibition to overcome AR-driven resistance.

    2026 · Open MIND · Figg, William D

    2026
  9. A patient‐centred approach to translate remote cognitive assessments into clinical practice

    2025 · Alzheimer s & Dementia · Blane, Jasmine, Forster, Shona, Lucas, Anna et al.

    2025
  10. Translating FRESCO clinical trial evidence into practice: fruquintinib as post-standard third-line therapy followed by trifluridine/tipiracil in a patient with mCRC without targetable mutations.

    2025 · PubMed · Biachi, Tiago, Shostak, Jessica

    2025

Command palette

Jump anywhere, run any action.